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Background: Calcium (Ca2+) signalling is fundamental for host cell invasion, motility, in vivo synchronicity and
sexual differentiation of the malaria parasite. Consequently, cytoplasmic free Ca2+ is tightly regulated through the
co-ordinated action of primary and secondary Ca2+ transporters. Identifying selective inhibitors of Ca2+ transporters
is key towards understanding their physiological role as well as having therapeutic potential, therefore screening
systems to facilitate the search for potential inhibitors are a priority. Here, the methodology for the expression of a
Calcium membrane transporter that can be scaled to high throughputs in yeast is presented.
Methods: The Plasmodium falciparum Ca2+/H+ antiporter (PfCHA) was expressed in the yeast Saccharomyces
cerevisiae and its activity monitored by the bioluminescence from apoaequorin triggered by divalent cations, such
as calcium, magnesium and manganese.
Results: Bioluminescence assays demonstrated that PfCHA effectively suppressed induced cytoplasmic peaks of Ca2+,
Mg2+ and Mn2+ in yeast mutants lacking the homologue yeast antiporter Vcx1p. In the scalable format of 96-well
culture plates pharmacological assays with a cation antiporter inhibitor allowed the measurement of inhibition of the
Ca2+ transport activity of PfCHA conveniently translated to the familiar concept of fractional inhibitory concentrations.
Furthermore, the cytolocalization of this antiporter in the yeast cells showed that whilst PfCHA seems to locate to the
mitochondrion of P. falciparum, in yeast PfCHA is sorted to the vacuole. This facilitates the real-time Ca2+-loading assays
for further functional and pharmacological studies.
Discussion: The functional expression of PfCHA in S. cerevisiae and luminescence-based detection of cytoplasmic
cations as presented here offer a tractable system that facilitates functional and pharmacological studies in a high-
throughput format. PfCHA is shown to behave as a divalent cation/H+ antiporter susceptible to the effects of cation/H+
inhibitors such as KB-R7943. This type of gene expression systems should advance the efforts for the screening of
potential inhibitors of this type of divalent cation transporters as part of the malaria drug discovery initiatives and for
functional studies in general.
Conclusion: The expression and activity of the PfCHA detected in yeast by a bioluminescence assay that follows the
levels of cytoplasmic Ca2+ as well as Mg2+ and Mn2+ lend itself to high-throughput and quantitative settings for
pharmacological screening and functional studies.
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Ca2+ signalling drives a myriad of events in the Plasmodium.
falciparum life cycle. They include erythrocyte invasion [1-3],
in vivo synchronicity in the erythrocytic cycle [4], together
with sexual differentiation, motility and invasion by ookinetes
and sporozoites in the mosquito vector [5-7]. As in any
eukaryote the parasite’s concentration of cytosolic free
Ca2+ is tightly maintained at 50-150 nM [8,9]. In eukar-
yotes this is achieved by its active sequestration into
various organelles and/or extrusion to extracellular
space. Transporters that could mediate this activity in
P. falciparum include two Ca2+ ATPases, a low-affinity
transporter PfATP4 [10] and a higher affinity SERCA-
like Ca2+ ATPase PfATP6 [11,12]. Intracellular Ca2+ in
Plasmodium has been found in acidic compartments (e.g.
food vacuole with a calculated free Ca2+ of 0.4-2 μM)
[9,13,14]. Ca2+ sequestration has also been observed in the
malaria parasite’s mitochondrion [15,16]. Besides Ca2+
pumps, low-affinity secondary transporters that facilitate
the membrane transport of Ca2+ and other divalent cations
(e.g. Mg2+, Mn2+) into organelles or through plasma mem-
brane using a proton (in lower eukaryotes and plants) gra-
dient in the opposite direction (Ca2+/H+ exchangers or
antiporters) are known to mediate the dissipation of
cytoplasmic peaks of Ca2+ [17,18]. In this context a P.
falciparum Ca2+/H+ antiporter (PfCHA) homologue to
the family of CAtion eXchangers (CAX, Transporter Clas-
sification Database 2.A.19.2) [19] has been reported and
characterized in oocytes of X. laevis as a divalent cation
(Ca2+, Mn2+ and possibly Mg2+)/H+ exchanger [20].
Saccharomyces cerevisiae is a highly developed and
widely used model organism. Furthermore, S. cerevisiae
has become a model for eukaryotic Ca2+ homeostasis
[21,22]. In the present work, PfCHA has been expressed
in the yeast vcx1Δ (VaCuolar Ca2+/H+ eXchanger) gene
knock-out mutant. A bioluminescence apoaequorin re-
porter system has been used to allow the detection of
cytoplasmic Ca2+ in vcx1Δ where PfCHA is shown to be
able to re-establish Ca2+ mobilisation from cytoplasm. In
the apoaequorin system aequorin catalyses the oxidation
of an imidazolopyrazinone (coelenterazine) upon Ca2+
binding and light is emitted from the oxidized and
excited state of this chromophore that exists tightly
bound to aequorin. In vitro, Ca2+ binding to apoae-
quorin triggers the emission of blue light (469 nm),
although other activating cations such as trivalent
lanthanides [23] and divalent Mn2+ and Mg2+ are also
known to bind aequorin via three EF-hand Ca2+-binding
sites [24].
Interestingly, whilst in the parasite PfCHA is reported
to be sorted to the mitochondrion [20], in S. cerevisiae
the exchanger is sorted to the vacuole. This finding
offers further practical advantages for the studies of a
membrane transporter such as PfCHA since yeastvacuoles are their main Ca2+ storage compartments.
Yeast is an attractive organism for recombinant protein
production as it combines highly developed genetic sys-
tems and ease of use with reductions in time and costs.
Moreover, due to the challenging nature of expressing
functional membrane proteins a yeast expression system
for PfCHA is a valuable tool for further functional stud-
ies and pharmacological screens. To this extent, the 96-
well format was used to further demonstrate divalent
cation (i.e. Ca2+, Mg2+, Mn2+) transport by PfCHA in
vcx1Δ yeast cells and present an inhibition assay with a
cation antiporter inhibitor as a proof of concept of the
opportunities offered by this expression system for the
search of PfCHA inhibitors.
Methods
Gene cloning
Total RNA from P. falciparum 3D7 was extracted with
Trizol (Invitrogen) following manufacturer’s protocol
using parasites harvested from standard cultures [25].
Gene sequences used as reference were downloaded
from PlasmoDB5.3 [26] and GenBank [27]. The poly-
merase chain reaction (PCR) product from total RNA
for PFF0170w (PfCHA) was cloned in the pCRII-Topo
vector (Invitrogen), and subcloned in the shuttle vectors
of the pGREG series [28] between NotI and BamHI restric-
tion sites obtained from Euroscarf. Primers for PFF0170w
were 5’-ATGGTTATGGGTAGAGTTC and 5’-TTATGAT
GTATCAAACCAG. The S. cerevisiae VCX1 gene was dir-
ectly cloned into pGREG505 using the following primers:
5’-gaattcgatatcaagcttatcgataccgtcgacaGGCTGCTGATAG
CAAATAAA and 5’- gcgtgacataactaattacatgactcgaggtcgac
GAATTTCTGCGCTACTGTTC. pGREG505 vector has
the LEU2 selectable marker and the GAL1 promoter.
Escherichia coli TOP10 cells (Invitrogen) were routinely
used as recombinant plasmids host. For bioluminescence
measurements of cytosolic Ca2+ yeast cells were trans-
formed with a plasmid carrying the aequorin gene [29].
This gene cloned in a pSEY8 plasmid under ADH3 pro-
moter was kindly provided by David M. Bedwell (University
of Alabama at Birmingham). Reverse transcription PCR
and real-time PCR with iQ SYBR Green Supermix (Bio-
Rad) in yeast were performed using total RNA extracted
with RiboPure-Yeast (Ambion/Applied Biosystems, Austin,
TX, USA) following manufacturer's instructions. cDNA
was synthesized using ThermoScript (Invitrogen), and
PCR amplifications using Platinum Taq High Fidelity
(Invitrogen).
Yeast strains and media
Yeast Saccharomyces cerevisiae haploid strain Y03825
(MATa,his3Δ1,leu2Δ0,met15Δ0,ura3Δ0,YDL128w::kanM
X4) was obtained from the European Saccharomyces
cerevisiae Archives for Functional Analysis (Euroscarf )
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(YDL128w, [31]) is replaced by the kanMX4 gene that in
yeast provides a geneticin (G418, Sigma G8168) resistant
phenotype. BY4741n is the isogenic and haploid parental
strain (Euroscarf Y00000). Yeast cells were transformed by
the DMSO-based method [32]. Yeast were grown on
complete YPD (yeast-peptone) medium with 2% (w/v) D-
glucose, or minimal synthetic medium (SM) with 2% (w/
v) glucose or 2% (w/v) galactose as carbon sources, and
strain-specific required nutrients and 400 μg/ml G418
[33].
Apoaequorin luminescence assay
Apoaequorin assays were adapted from Miseta et al [34].
pSEY8 vector (pAEQ with a URA3 selection marker)
expresses the soluble calcium-binding protein aequorin
[29]. Cells carrying pSEY8 and the pGREG505 recombin-
ant vectors were grown in SD and 2% (w/v) glucose until
they reached exponential growth to 0.5-0.6 OD600/ml.
The cultures were then washed twice in SD medium and
grow a further four hours in SD with 2% (w/v) galactose
to induced gene expression. Ten OD600 units of cells were
resuspended in 180 μl of test medium –TM- (0.17% (w/v)
YNB, 2 mM EGTA, 40 mM MES-Tris, pH 6.5) after two
washes with the same medium. To equilibrate cytosolic
aequorin with its allosteric group, 20 μl of 0.6 mM coelen-
terazine (Fluka Biochemica 07372) dissolved in methanol
were added and the cell suspension incubated for 30 min
at room temperature. Cells were then washed twice in
TM. The final pellet was resuspended in 1 ml of TM and
allowed to equilibrate for 30 min at room temperature.
After detecting the baseline light emission 1 ml of 1 M of
CaCl2 was added. Final concentrations of CaCl2 were 50
mM or 500 mM in 2 ml total volume. For the multi-well
plate experiments 0.1 OD600 were plated in 0.1 ml
volumes and 1 M of the divalent cation salts (CaCl2,
MgCl2 or MnCl2) were added in 0.1 ml to make 0.5 M
final concentrations in 0.2 ml total volume. Light emission
was collected from the 2 ml assays with a CliniLumat
Berthold luminometer at intervals of 2 seconds or from
the 0.2 ml multi-well assays with a LumiStarOmega
luminometer (BMG Labtech) plate reader at 0.5 seconds
intervals. Where indicated the samples were incubated
with dimethylsulphoxide (DMSO) alone or with Bafilomy-
cin A1 dissolved in DMSO (1 μM final concentration,
Sigma B1793) or KB-R7943 dissolved in DMSO (Calbio-
chem 420336) for 30 minutes at room temperature prior
to the addition of CaCl2.
Indirect immunofluorescence assay (IFA)
Yeast membranes were extracted and purified as in
Fisher et al [35]. Indirect immunofluorescence in yeast
cells was performed as in Stearman et al [36]. Polyclonal
IgG antibody Anti-PfCHA (0.568 mg/ml) was producedin rabbit by GenScript (Piscataway, NJ, USA) against a
14 aa synthetic peptide representing positions 73-86 in
the amino terminal sequence of PfCHA and used at
1:100 dilutions. The Anti-actin antibody was purchased
from Sigma (A2066) and used at 1:500 dilutions. The
secondary antibody anti-rabbit IgG-FITC was also
purchased from Sigma (F0382) and used at 1:1000 dilu-
tions. Cells were mounted with VectaShield HardSetTM
mounting medium (Vector Labs Burlingame, CA, USA)
and observed in a confocal microscope Zeiss Axiovert
200 M (L5M 5Pascal laser modules). Propidium iodide
(Fluka 70335) was used for nuclei localization at 10 μg/ml
room temperature for 30 minutes after treating with 100
μg/ml of RNaseA for 30 minutes.Results
PfCHA restores mobilization of cytoplasmic Ca2+ in
Saccharomyces cerevisiae vcx1Δ
Yeast vcx1Δ has a significant defect in the rapid Ca2+ se-
questration response to high cytosolic levels of this cat-
ion [34]. Recombinant pGREG505 vectors carrying
PfCHA or yeast VCX1 genes as well as the empty vector
control were transformed into vcx1Δ. For the detection
of cytosolic Ca2+ by bioluminescence, these strains were
subsequently transformed with a vector carrying the
apoaequorin gene (pSEY8-AEQ). Positive colonies were
selected for growth in the absence of leucine and uracil
and in the presence of 400 μg/ml of geneticin in SD
medium. The presence of the recombinant vectors was
verified and their RNA expression monitored by reverse
transcription and PCR amplification (Additional file 1).
Expectedly, there is a relative low expression of the heter-
ologous PfCHA gene in the vcx1Δ mutant in comparison
to the native yeast VCX1 gene. Truncated gene transcrip-
tion is a known phenomenon in yeast expressing AT-rich
P. falciparum genes [37] and this is evident in the differ-
ential amplifications for fragments in comparison to full-
length VCX1 and PfCHA genes (Additional file 1B).
Nonetheless the bioluminescence assays as presented
below showed that these levels of expression were suffi-
cient to detect functional protein in the yeast vcx1Δ
background.
The medium used to process cells for the apoaequorin
bioluminescence assays contains 2 mM EGTA to reduce
extracellular Ca2+ concentration in the test medium - TM
(~6 μM [34]). Four different samples were examined: the
parental isogenic and haploid strain BY4741n, the vcx1Δ
mutant containing the pGREG505 vector only (vcx1Δ+
p505), vcx1Δ carrying the recombinant pGREG505-VCX1
(vcx1Δ+VCX1), and vcx1Δ carrying the recombinant vec-
tor pGREG505 with PfCHA (vcx1Δ+PfCHA). All four
strains responded with a sharp elevation in cytosolic Ca2+
levels when 50 mM CaCl2 was added (Figure 1A).
Figure 1 PfCHA rescues yeast Saccharomyces cerevisiae Ca2+/H+ antiporter mutant. A. Apoaequorin bioluminescence of cytosolic Ca2+
following exposure to extracellular Ca2+. Light emission was initially recorded for 8 seconds in low Ca2+ medium. CaCl2 was subsequently added
to 50 mM final concentration in 2 ml total volume. The luminescence recorded for 90 seconds is shown. BY4741n is the haploid isogenic yeast
parental strain, vcx1Δ+p505 is the vcx1Δ knock-out carrying the pGREG505 plasmid only, vcx1Δ+ VCX1 and vcx1Δ+PfCHA are the same knock-
out strain but carrying recombinant plasmids with the homologueous VCX1 gene or the Plasmodium falciparum PfCHA gene, respectively. B.
Apoaequorin luminescence measurements following a challenge with 500 mM extracellular CaCl2. Addition of CaCl2 is indicated by the arrows.
Data represent means and standard deviations of three experiments (n=3).
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were registered for 8 seconds to establish the basal line.
As expected vcx1Δ mutant showed the highest peak of
cytosolic Ca2+ level and the reference BY4741n strain pre-
sented the lowest signal with a 10-fold difference between
them. Mutant vcx1Δ cells expressing the homologue
VCX1 closely followed the Ca2+ levels of BY4741n. Signifi-
cantly, vcx1Δ cells expressing the heterologous PfCHA
also followed the extrusion of cytosolic Ca2+ after the ini-
tial peak. Although as anticipated less efficiently than the
homologue VCX1 gene (Figure 1A). The difference in the
areas under the curve (AUC) between the cytosolic levels
of Ca2+ in the mutant vcx1Δ carrying the plasmid control
and the vcx1Δ carrying the recombinant plasmid with
PfCHA was significant (p < 0.005, Student’s two-tailed
test). Replacing D-galactose with D-glucose, and thereby
inhibiting the transcription of genes under the GAL1 pro-
moter of the pGREG505 vector, impaired the expression
of both VCX1 and PfCHA (Additional file 2). The pheno-
type of the vcx1Δ mutant and the different levels of rescue
by VCX1 or PfCHA detected as cytosolic levels of Ca2+
were more apparent (p <0.0001 and p <0.001, respectively,
Student’s two-tailed test) when even higher concentrations
(500 mM) of CaCl2 were applied as external Ca
2+
(Figure 1B).
Ca2+/H+ antiporters can be inhibited by interfering
with the transmembrane H+- gradient [38] and thus
PfCHA was expected to be sensitive to bafilomycin
A1 a vacuolar-specific V-type ATPase inhibitor. Fol-
lowing a pre-incubation with bafilomycin A1 (1 mM,30 minutes) Ca2+ shock experiments were carried out as
described above with 500 mM CaCl2. For all the strains,
bafilomycin A1 treatment resulted in a reduced ability of
the yeast cells to recover from the Ca2+ challenge
(Figure 2). The reference strain BY4741n showed a three-
fold increased cytosolic Ca2+ peak (Figure 2A), while the
vcx1Δ mutant peak response was slightly but not signifi-
cantly higher in the presence of bafilomycin A1
(Figure 2A) than the DMSO control. As with the strain
carrying the yeast Ca2+/H+ exchangers (p <0.0001, Stu-
dent’s two-tailed test), treatment with bafilomycin A1 also
affected the ability of PfCHA-carrying yeast cells to re-
cover from the Ca2+ challenge (p <0.001, Student’s two-
tailed test) (Figure 2B). Taken together, the described
phenotype rescue experiments carried out with the yeast
S. cerevisiae vcx1Δ mutant are indicative of the functional
expression of the heterologous PfCHA. Consistent with its
expected mechanism of transport PfCHA is dependent on
a proton membrane gradient sensitive to the vacuolar-
specific inhibitor bafilomycin A1.
Further functional studies in a scalable format
Yeast cultures of vcx1Δ carrying the pGREG505 vector only
(vcx1Δ+p505) or the recombinant vectors pGREG505–
VCX1 (vcx1Δ+VCX1) and pGREG505-PfCHA (vcx1Δ+
PfCHA) were processed for apoaequorin assays as
described in Methods. The parental strain BY4741n was
not used for assays in the multi-well plates as the mutant
carrying the homologue VCX1 gene behaved equivalently
in the Ca2+ loading assays presented above. In 96-well
Figure 2 PfCHA Ca2+/H+ antiporter function in yeast is inhibited by bafilomycin A1. Cytoplasmic Ca2+ dependent apoaequorin
luminescence was measured following pre-incubation with the V-type ATPase inhibitor bafilomycin A1 (BF). Inhibitor-free controls contained
concentrations of solvent (DMSO) equivalent to the solvent present in the BF sample. A. Data from the parental BY4741n strain and the vcx1Δ
mutant carrying the plasmid only (vcx1Δ+p505). B. vcx1Δ carrying the yeast VCX1 (vcx1Δ+ VCX1) or PfCHA (vcx1Δ+ PfCHA). Time of the addition
of CaCl2 is indicated by the arrows. Data represent means of three experiments (n = 3).
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taining a number of cells equivalent to 0.1 OD unit
(OD600). After establishing the base line for 5 seconds Ca
2+,
Mg2+ or Mn2+ were injected as 1 M chloride salts on to the
selected wells (0.1 ml) to render 0.5 M final concentrations.
The luminescence signals were recorded for 60 seconds at
intervals of 0.5 seconds. The luminescence peaks were
sharper and the area under the curves was smaller than
those originated by the larger cell volumes and densities used
previously with equivalent final concentrations of Ca2+
(Figure 1B). The dissipation of free cytosolic Ca2+ by Vcx1p
and PfCHA was significant (p <0.001 and p <0.01, respect-
ively, Student’s two-tailed test) by comparison to the vector
only control demonstrating the functionality of the assays in
the multi-well format (Figure 3A). Furthermore, the effective
movement of free Mg2+ (Figure 3B) and Mn2+ (Figure 3C)
from the cytosol by PfCHA was also apparent and significant
(p <0.01). Noteworthy, the initial functional characterization
of PfCHA as a Ca2+ and Mn2+ transporter did not present
direct transport activity of Mg2+ by PfCHA when expressed
in X. laevis oocytes [20]. However, a lower affinity of PfCHA
for Mg2+ was inferred from competition studies against
45Ca2+ transport. Here, the yeast expression system seems to
substantiate the evidence of Mg2+ being a substrate for
PfCHA-mediated transport. On the other hand, the yeast
Vcx1p antiporter is known to lack Mn2+ transport [39]
which is in agreement with the observed lack of suppression
of the Mn2+ cytosolic peak in the cells expressing the gene
product of VCX1 (Figure 3C).The effective sequestration of cytosolic Mg2+ was cor-
roborated when cells pre-loaded with Mg2+ (0.2 M final
concentration) had a subsequently bolus of Ca2+ (0.5 M
final concentration) (Figure 3D). The rationale behind
this assay takes into account the fact that Mg2+ and Ca2+
share their binding sites in aequorin. Aequorin is known
to bind other divalent cations besides Ca2+ via one or
more of its three EF-hand Ca2+-binding sites and Mg2+
has been shown to compete for the same sites that Ca2+
occupies when bound to aequorin [40,41]. Thus pre-
loading with Mg2+ will be expected to reduce any signal
from a subsequent Ca2+ injection if the former has not
been effectively sequestered from the cytosol. Therefore,
the magnitude of the luminescence signal from Ca2+ will
be in proportion to the effective sequestration of Mg2+
from cytoplasm. As observed in Figure 3D the injection
of Mg2+ at 2 seconds showed the expected signal in re-
sponse to the presence of this divalent cation in the
cytosol. When the injection of Ca2+ followed at 5 sec-
onds, the three different cell groups presented a delayed
luminescence peaks in comparison to the cells that were
not pre-loaded with Mg2+ (Figure 3D). The magnitude
of the luminescence peak generated by Ca2+ seems to re-
flect rather accurately the capacity for transport of cyto-
plasmic Mg2+ (Figure 3D). The Ca2+-dependent signal
was respectively 12 times, 1.5 times and 3.5 times on
average lower in the cells pre-loaded with Mg2+ than
those that were not for vcx1Δ+ p505, vcx1Δ+VCX1 and
vcx1Δ+PfCHA. Magnesium was then more effectively
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Figure 3 Divalent cation transport activities in multi-well plates. A-C. Apoaequorin bioluminescence for cytosolic Ca2+ , Mg2+ and Mn2+,
respectively. Cell cultures were distributes in 0.1 ml volumes in 96-well plates at 0.1 OD600 densities. A bolus of 0.1 ml 1 M of CaCl2, MgCl2, or
MnCl2 was added at 5 seconds and the relative light units (RLUs) were recorded every 0.5 second for 60 seconds. The signals for experimental
group were normalized against the RLU of the 5 second point for that group (RLUt (0 .. 22)/RLUt = 5) and the signals for the first 22 seconds are
presented. D. Dual magnesium and calcium transport. Cell cultures in 0.08 ml volumes were distributed in 96-well plates at 0.1 OD600 density.
MgCl2 was added (1M, 0.02 ml) at 2 seconds followed by 0.1 ml of 1M CaCl2 at 5 seconds. RLUs were normalized as in A–C. Data presented is
representative of four experiments for A–C and three experiments for D.
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vcx1p antiporter and with a significantly lack of trans-
port for Mg2+ in the knock-out stain.
PfCHA as well as Vcx1p, however, sequestered Ca2+ at
slower rates when cells had been pre-loaded with Mg2+.
Yeast Vcx1p dissipated the Ca2+ signal 13 times slower
on average (means 0.32 RLUs/second vs 0.025 RLUs/sec-
ond) in the presence of Mg2+, with PfCHA rates of Ca2+
clearance falling to 63 times on average (means 0.44
RLUs/second vs 0.007/second) significantly slower when
in the presence of Mg2+. Clearance rates for Ca2+ were
calculated from the highest point to the first point of the
plateau for each curve (Ca2+ only versus Ca2+ after Mg2+
load). The delayed response to cytoplasmic Ca2+ is inter-
preted as the time required for Ca2+ to displace Mg2+
from the aequorin EF-hand Ca2+-binding sites, and the
slower clearance rates as the inhibitory effects of Mg2+
on the transport of Ca2+ by Vcx1p and PfCHA. Interest-
ingly, by comparison PfCHA seems to be a more profi-
cient transporter of Mg2+ given that a higher proportionwas cleared from cytoplasm by PfCHA (Ca2+ peak lower
in cells loaded with Mg2+). Also, PfCHA seems to have a
higher affinity for Mg2+ than the yeast Vcx1p since the
rate of Ca2+ sequestration of cytosolic Ca2+ in cells
loaded with Mg2+ was most affected in the cells expres-
sion PfCHA. Pre-loading with Mn2+ was less informative
due to the overlapping patterns with the signal generated
by Ca2+ (data not shown). This is observed as the result of
Mn2+ occupying a EF-hand Ca2+-binding site different
from the two sites that Ca2+ binds in aequorin [23,24].
Inhibitory assays with KB-R7943
In the absence of specific Ca2+/H+ antiporter inhibitors KB-
R7943 was used to illustrate an inhibitory assay for PfCHA
using the yeast expression system. KB-R7943 is an inhibitor
of Na+/Ca2+ antiporters [42-44] although it inhibits more
avidly members of the canonical transient receptor poten-
tial channel (TRPC) family [45]. More recently KB-R7943
was used in the functional characterization of PfCHA
expressed in X. laevis oocytes [20] where it reduced by
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cultures were incubated for 30 minutes at room
temperature in several concentrations of KB-R7943 after
the cells had been treated with coelenterazine as in Meth-
ods. The effect of this inhibitor on the sequestration of
cytosolic Ca2+ was apparent in all three experimental
groups of the vcx1Δ knock-out strain carrying the empty
vector pGREG505 (vcx1Δ+p505) or expressing VCX1
(vcx1Δ+VCX1) and PfCHA (vcx1Δ+PfCHA) (Figures 4A–
4C). The luminescence signals increased in proportion
to the concentration of KB-R7943 in all three groups:
higher peak at injection time and larger areas under the
curve (AUC) throughout the detection time of 60 sec-
onds. Next, the observed luminescence patterns were
translated to inhibitory dose–response curves. The
ratios of the AUC (between 4 and 16 seconds) of the lu-
minescence signals from the DMSO controls over the
AUC for the signals from the KB-R7943 samples were 0
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increasing concentrations of KB-R7943. The profiles for the first 30 seconds are
CaCl2 (1 M, 0.1 ml) was added at 5 seconds to wells containing 0.1 ml of cells
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three experimental groups (Figures 4D–4F). All three
vcx1Δ yeast mutants, carrying the vector only as well as
the yeast carrying Vcx1p or the Plasmodium PfCHA,
had their mobilization of cytosolic Ca2+ inhibited by
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their transport was inhibited by 50% (the AUC of the
luminescence signal had double with respect to the
DMSO sample) was calculated to be 7.5 μM, 12.5 μM
and 17.5 μM of KB-R7943 for vcx1Δ+pGREG505, vcx1Δ+
VCX1 and vcx1Δ+PfCHA, respectively (Figures 4D–4F).
The higher sensitivity of the knock-out strain to this in-
hibitor in comparison to either of the vcx1Δ expressing
the Ca2+/H+ antiporters from yeast or Plasmodium
could be explained if the S. cerevisiae TRPC homologue
Yvc1p, a vacuolar Ca2+- and mechanosensitive TRP cat-
ion channel, mediates the rapid initial response for se-
questration of Ca2+ in vcx1Δ cells. TRP channels areC
 15  20  25  30
(seconds)
KB-R7943
x1Δ+VCX1
0.2 mM
0.1 mM
0.05 mM
0.025 mM
0.012 mM
DMSO
 0
 1
 2
 3
 4
 5
 6
 7
 8
 9
 0  5  10  15  20  25  30
R
LU
t (0
 .. 
30
) /
 R
LU
(D
MS
O,
 t =
 5)
Time (seconds)
KB-R7943
vcx1Δ+PfCHA
0.2 mM
0.1 mM
0.05 mM
0.025 mM
0.012 mM
DMSO
F
.01  0.1
7943 mM
C50 = 12.3 ± 2.2 μM
Slope = 1.66
 0
 20
 40
 60
 80
 100
 0.001  0.01  0.1
Σ τ
 =
 4
τ 
=
 1
6  
R
LU
D
M
SO
 
/ Σ
τ 
=
 4
τ 
=
 1
6  
R
LU
IN
H
KB-R7943 mM
IC50 = 17.7 ± 4.12 μM
Slope = 1.27
 
R
LU
2+ - dependent luminescence at increasing concentrations of KB-R7943.
ent in the culture with the highest concentration of KB-R7943) or in
presented for 12.5 μM, 25 μM, 50 μM, 100 μM and 200 μM of KB-R7943.
(0.1 OD600) and the signals recorded for 60 seconds. RLUs were
)/RLUt = 5 ). Data represent the averages of four experiments.
d with nine concentrations at two-fold dilutions from 0.2 mM KB-R7943.
mples were divided by the AUC for the different concentrations of KB-
ions as percentages. The data were fitted and the IC50 and slopes inferred
e limit to the left of the sigmoid (highest signal, lowest concentration),
ncentration equivalent to half of the signal of the left limit (IC50), and “S”
erent experiments.
Salcedo-Sora et al. Malaria Journal 2012, 11:254 Page 8 of 11
http://www.malariajournal.com/content/11/1/254targets of KB-R7943 and have been shown to have their
current blocked by IC50 in the range of 0.46–1.38 μM
of this inhibitor. These data therefore demonstrate the
proof of concept that the yeast system using the vcx1Δ
knock-out and apoaequorin (aequorin + coelentarazine)
as a divalent cation reporter delivers a suitable screen-
ing setting for high throughput search for molecules
with inhibitory activity against P. falciparum’s Ca2+/H+
antiporter PfCHA.
Cytolocalization of PfCHA in Saccharomyces cerevisiae
Using a primary antibody (Anti-PfCHA) raised against a
14 aa synthetic peptide representing residues 73-86 of
PfCHA, indirect immunolocalization assays were per-
formed in the transformed yeast. Yeast vcx1Δ mutants
carrying pGREG505-PfCHA showed a fluorescent signal
derived from the vacuole (tonoplast) (Figure 5A, bottom
panels) while the control samples using the strain carry-
ing pGREG505-VCX1 (Figure 5A, top panels) failed to
generate the same fluorescent signal. The specificity of the
Anti-PfCHA used here was assessed probing blots with
membrane-enriched fractions of the same vcx1Δ mutant
expressing the recombinants VCX1 or PfCHA (Figure 5B).
These observations in addition to the functional data pre-
sented above, indicate that in contrast to the mitochondria
localization of PfCHA in P. falciparum and in the plasma
membrane when expressed X. laevis [20], in S. cerevisiae
the same protein is sorted to the vacuole membrane.
Discussion
A transient rise in cytosolic free Ca2+ generated when
influx temporarily exceeds efflux usually functions as an
intracellular signal. Calcium-proton exchangers are low-Figure 5 PfCHA protein localizes to the yeast vacuole membrane. A. I
expressing the recombinants pGREG505-VCX1 and pGREG505-PfCHA. Brigh
panels show a sample from cells carrying pGREG505-VCX1 and stained with
primary Anti-PfCHA. Bottom panels shown FITC fluorescence localizing arou
probed with Anti-PfCHA (1:100). B. Anti-PfCAX Western Blot. Top panel sho
The expected molecular size for PfCHA is approximately 49kDa. Samples ar
vector (p505), or the recombinant pGREG-VCX1 or pGREG-PfCHA vectors. Bo
markers as indicated.affinity cytosolic export systems that coupled to the
thermodynamically downhill exchange flux of H+ dissipate
cytosolic increases of Ca2+ [21]. PfCHA is part of the
CAXs (for CAtion eXchangers) group of integral mem-
brane proteins that transport Ca2+ energized by the elec-
trochemical gradient established by proton pumps such as
H+-ATPases and H+-pyrophosphatases [17]. Accordingly,
CAX proteins had previously been located in acidic com-
partments in plants [17] and yeast [21] where they seques-
ter calcium from the cytoplasm. In P. falciparum however,
the CAX homologue PfCHA seems to localize and per-
form Ca2+ (as well as Mn2+) exchange in the mitochon-
drion of this parasite [20]. In this organelle PfCHA is
proposed to mediate the extrusion of peaks of Ca2+ from
the matrix when the mitochondrion is going through tran-
sient Ca2+ overloads [20].
In order to detect functional PfCHA in S. cerevisiae, the
apoaequorin luminescent response to divalent cations was
used as a reporter system to follow cytosolic levels of Ca2+,
Mg2+ and Mn2+ [29]. Apoaequorin bioluminescence assays
in yeast have been applied in studies of cellular Ca2+ homeo-
stasis [34,46], including the functional characterization of
heterologous Ca2+ transporters such as the A. thaliana
Ca2+/H+ antiporters (AtCAX) [47]. Here, PfCHA was
shown to rescue the ability to mediate the dissipation of
cytosolic peaks of Ca2+, Mg2+ and Mn2+ in the yeast vcx1Δ
mutant and that this activity was sensitive to inhibition of
the H+ transmembrane gradient by a vacuolar-ATPase in-
hibitor as well as the Na+/H+ antiporter and TRP channels
inhibitor KB-R7943. The levels of cytosolic Ca2+, Mg2+
and Mn2+ reported by the apoaequorin luminescence
show apparent and significant cytosolic dissipation of all
three of these divalent cations by PfCHA in vcx1Δ cells.ndirect immunofluorescence assay with Anti-PfCHA in yeast vcx1Δ
t field, dark field, and the merge in columns from left to right. Top
propidium iodide for staining of the nucleus in addition to the
nd the yeast tonoplast of vcx1Δ cells carrying pGREG505-PfCHA and
ws the signal given by Anti-PfCHA on the yeast membrane extracts.
e labelled as the yeast vcx1Δ mutant carrying the empty pGREG505
ttom panel show the control with Anti-actin antibody. Molecular mass
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tion point at PfCHA to behave as a divalent cation/H+ ex-
changer that in yeast functions as a vacuolar membrane
transporter. As a consequence of the role of the proton
gradient in the function of this type of calcium exchanger
potential inhibitors of PfCHA will have to be tested for
their own capacity to inhibit proton pumps.
In yeast it is estimated that at least 90% of the total
1.5-4 mM of cellular Ca2+ is sequestered within the yeast
vacuole in stable complexes (e.g. with polyphosphates)
as well as free Ca2+ [48] allowing the cell basal cytosolic
levels to be kept around 50-80 nM. The accumulation of
vacuolar Ca2+ in yeast is maintained through the com-
plementary action of Vcx1p [48,49] and the Ca2+ ATPase
Pmc1p [50]. As with other CAX proteins Vcx1p is a low
affinity high capacitance facilitative Ca2+ transporter that
responds to sudden increments of the cytosolic Ca2+ by
rapid sequestration of this cation into the vacuole in ex-
change for two protons down a proton gradient (vacu-
olar pH 5.5-6.2 vs cytoplasmic pH 7.0) [38,51].
It is noteworthy that in S. cerevisiae, cells have to be
exposed to seemingly excessive concentrations of these
cations (50 mM to 500 mM external levels of their
chloride salts) in order to reach measurable cytosolic
transient elevations of these ions. When exposed to 50
mM S. cerevisiae cytosolic levels of Ca2+ are measured
to be in the region of 250-290 nM (basal concentrations
50–80 nM) that increases further to 320-350 nM when
the external Ca2+ is raised to 400 mM [34]. The vcx1Δ
mutant undergoes transient elevations slightly higher
with cytosolic calcium concentrations of approximately
400 nM and 510 nM when in the presence of 50 mM
and 400 mM of Ca2+, respectively [34]. Coincidentally,
these cytosolic concentrations of Calcium are far from
the 2 mM reported as the Km of PfCHA for Ca2+ [20],
or the Km for Ca2+ reported for other CAX proteins (up
to 25μM) [21]. Nonetheless, the rates of divalent cations
transported by PfCHA effectively dissipated 40 – 55% of
the cytosolic transient elevations in the vcx1Δ back-
ground (Figures 1-Figure 3).
The localization of PfCHA to the yeast vacuole is not
altogether surprising as this organelle seems to be the
default localization for foreign proteins in S. cerevisiae.
In S. cerevisiae proteins are sorted to the vacuole by at
least four different pathways [52]: (i) sorting of vacuolar
proteins vs cell surface proteins in the early stages of the
secretory pathway, (ii) endocytic engulfing of material
from the plasma membrane, (iii) cytoplasm-to-vacuole
targeting pathways that do not transit the early stages of
the secretory pathway, and (iv) the de facto inheritance
of vacuolar material by daughter cells during cell div-
ision. However, in S. cerevisiae membrane proteins lack-
ing motifs or otherwise protein structure information for
cellular localization are predominantly delivered to thevacuole membrane [53,54]. Moreover, membrane pro-
teins have been shown to be delivered by default to the
yeast vacuole when high levels of protein expression –
overexpression – are achieved. The localization of mem-
brane proteins depends also on the length of their trans-
membrane domains [53], it is not possible to know a
priori the destination of a membrane transporter in a
heterologous expression system. In the yeast expression
system as reported here it is speculated that PfCHA is
sorted by a default mechanism to the yeast vacuole [55].
In eukaryotic cell hosts, the yeast S. cerevisiae is by far
the most advantageous gene expression system since it
is relatively inexpensive to culture and it is the most
genetically tractable eukaryotic system with excellent re-
combinant DNA tools. Additionally, recent advances
seeking to overcome the difficulties intrinsic to the ex-
pression of foreign proteins in yeast, particularly mem-
brane proteins, have rendered transgenic strains with
altered ribosomal content that seems to tolerate and
much improve heterologous gene overexpression
[56,57]. The successful expression of PfCHA in S. cerevi-
siae and its localization to the yeast vacuole permits a
very tractable system for further functional and pharma-
cological studies as exemplified here in multi-well
whole-cell cation transport and inhibitory assays.
Conclusions
Yeast offers a cost-effective and user-friendly gene ex-
pression system for further functional studies and
pharmacological screens of proteins from P. falciparum.
Particularly membrane transporters such as PfCHA that
are still very seldom successfully expressed in heterol-
ogous hosts. Moreover, the bioluminescence assay for
the detection of cytoplasmic Ca2+ as well as Mg2+ and
Mn2+ lends itself to high-throughput and quantitative
settings.
Additional files
Additional file 1: PfCHA and VCX1 RNA yeast expression. A. The
expression of Plasmodium PfCHA as well as yeast VCX1 was observed by
reverse transcription PCR using total RNA from the reference strain
BY4741n, the vcx1Δ mutant carrying the expression plasmid only (p505)
and the same mutant carrying the recombinant plasmid with either VCX1
or PfCHA. Forward and reverse primer position and sequences: PfCHA (64
- 488nt) (5’- AAAAATGTGCCCCCTATGAA, 5’-
TCCATTAAATTACCAAACGTAGCA), VCX1 (269 - 666nt) (5’-
GTAACACCATTGGGGGACTG, 5’-ATGGCTCCCTAGCTGGAAAT), and yeast S.
cerevisiae actin YFL039c (130 - 533 nt) (5’- ATGGTCGGTATGGGTCAAAA, 5’-
ATTCTCAAAATGGCGTGAGG). B. Real-time PCR using total RNA from the
vcx1Δ mutant carrying recombinant plasmids with VCX1 or PfCHA
following the amplification of either a fragment or the full gene for
VCX1–666 bp and VCX1-1236 bp respectively. Likewise for the PfCHA (488
bp fragment or entire gene of 1321 bp). Primers for total length genes as
in Methods. Evidently, RNA levels of PfCHA as full size gene are present
around three-fold lower than its homologous counterpart VCX1 while the
difference in the levels of shorter (truncated) transcribed fragments is
only half that difference.
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http://www.malariajournal.com/content/11/1/254Additional file 2: Phenotypic rescue of yeast Saccharomyces
cerevisiae vcx1Δ inhibited in presence of glucose. Conditions and
strains as in Figure 1A except that the culture medium contained D-
glucose instead of D-galactose which suppresses the activity of the GAL1
promoter present in pGREG505.
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